Drug Shortage Report for PYRIDOXINE HYDROCHLORIDE INJECTION, USP
Report ID | 238 |
Drug Identification Number | 02245215 |
Brand name | PYRIDOXINE HYDROCHLORIDE INJECTION, USP |
Common or Proper name | Pyridoxine |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | PYRIDOXINE HYDROCHLORIDE |
Strength(s) | 100MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS |
Packaging size | 1VL |
ATC code | A11HA |
ATC description | OTHER PLAIN VITAMIN PREPARATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-07-03 |
Actual start date | 2018-07-03 |
Estimated end date | |
Actual end date | 2018-08-03 |
Shortage status | Resolved |
Updated date | 2018-08-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v41 | 2018-08-07 | English | Compare |
v42 | 2018-08-07 | French | Compare |
v43 | 2018-08-07 | French | Compare |